WASHINGTON, D.C. (March 17, 2000) Featured speakers at BIO 2000's lunch Wednesday, March 29, will discuss a variety of topics, including the risks and benefits of agricultural biotechnology in developing nations, the Human Genome Project and racial diversity in the biomedical industry.
BIO 2000, March 26-30, in Boston is the annualInternational Meeting & Exhibition of the Biotechnology Industry Organization (BIO). More than 7,000 executives, scientists, patients, investment experts and government officials from about 40 nations are expected to attend the five-day conference at the Hynes Convention Center.
At Wednesday's lunch, Dr. Ismail Serageldin, chairman ofConsultative Group on International Agricultural Research (CGIR), will discuss the risks and benefits of applying biotechnology to tropical farming. CGIR, established in 1971, is the largest international cooperative effort aimed at reducing poverty, promoting sustainable agriculture for food security and encouraging sound management of natural resources throughout the developing world. Dr. Serageldin also is the World Bank's vice president of special programs.
In addition, Dr. Francis S. Collins, director of the NationalHuman Genome Research Institute, will discuss the Human Genome Project and Harvard Medical School's Dr. Joan Reede will talk about the Boston-based Biomedical Science Careers Program, which encourages minority students to pursue careers in the biomedical industry.
A full program of BIO 2000 conference activities is posted onBIO's website (www.bio.org) in the BIO 2000 News Room. Look here for selected highlights, featured speakers, contacts, a schedule of press conferences, pressroom hours and registration instructions.